Capital Flow Monitor · Sponsors · CIK 1693764

RECODE THERAPEUTICS, INC.

1140 O'Brien Drive, Menlo Park, CA, 94025 · 408-585-1700

Biotechnology · Corporation· inc. DELAWARE true

Fit score

—

Offering

$29.4M

Sold

$29.4M

% sold

100.0%

Investors

26

Min investment

$0

Exemption

506(b)

Filing history

FiledFormRuleOfferingSold% soldInvestors
2025-10-23 D ·current 506(b) $29.4M $29.4M 100.0% 26 EDGAR ↗

Related persons

Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.

  • Shehnaaz Suliman — Executive Officer / Director, Menlo Park, CA
  • Peter A. Thompson — Director, Menlo Park, CA
    3 other raises
  • Helen S. Kim — Director, Menlo Park, CA
  • Edward Hurwitz — Director, Menlo Park, CA
  • Rana Al-Hallaq — Director, Menlo Park, CA
  • Rakhshita Dhar — Director, Menlo Park, CA
    2 other raises
  • Alan Colowick — Director, Menlo Park, CA
    1 other raise
  • Patricia Millican — Director, Menlo Park, CA
  • Dean Mitchell — Director, Menlo Park, CA
  • Inai Park — Director, Menlo Park, CA
  • Basheer Zada — Director, Menlo Park, CA
  • David Lockhart — Executive Officer, Menlo Park, CA

Placement agents

  • No sales compensation reported — direct raise.

Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.